REYON PHARMACEUTICAL CO., LTD Logo

REYON PHARMACEUTICAL CO., LTD

Develops and manufactures APIs, generics, contrast agents, and biopharmaceuticals.

102460 | KO

Overview

Corporate Details

ISIN(s):
KR7102460003
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로 620 에이동 12층 (대치동, 미래에셋타워), 강남구

Description

REYON PHARMACEUTICAL CO., LTD. is a research-driven company engaged in the development and manufacturing of chemical and biopharmaceutical products. Its primary business areas encompass the production of Active Pharmaceutical Ingredients (APIs), a diverse portfolio of generic medicines, and contrast agents. The company leverages advanced synthesis know-how to supply high-value APIs to domestic and international partners. A key strategic focus is the development of next-generation biopharmaceuticals, including gene therapies for conditions like wet age-related macular degeneration and NK cell therapies for solid cancers. Reyon is also expanding its capabilities to offer contract development and manufacturing (CDMO) services for complex biologic drugs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-10-27 00:00
주식등의대량보유상황보고서(일반)
Korean 119.2 KB
2023-09-01 00:00
주식등의대량보유상황보고서(일반)
Korean 119.3 KB
2023-08-14 00:00
반기보고서 (2023.06)
Korean 1.4 MB
2023-07-27 00:00
기타경영사항(자율공시)
Korean 7.8 KB
2023-07-26 00:00
주식등의대량보유상황보고서(일반)
Korean 119.2 KB
2023-05-15 00:00
분기보고서 (2023.03)
Korean 1.3 MB
2023-04-27 00:00
기타경영사항(자율공시)
Korean 7.2 KB
2023-04-26 00:00
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 11.1 KB
2023-04-12 00:00
기타경영사항(자율공시)
Korean 6.6 KB
2023-03-31 00:00
정기주주총회결과
Korean 25.3 KB
2023-03-31 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.4 KB
2023-03-23 00:00
사업보고서 (2022.12)
Korean 1.6 MB
2023-03-21 00:00
감사보고서제출
Korean 18.9 KB
2023-03-14 00:00
주주총회소집공고
Korean 993.7 KB
2023-03-14 00:00
주주총회집중일개최사유신고
Korean 5.2 KB

Automate Your Workflow. Get a real-time feed of all REYON PHARMACEUTICAL CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REYON PHARMACEUTICAL CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for REYON PHARMACEUTICAL CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.